Waypoint Bio
PrivateLast Round
Series A
May 27, 2026
Total Funding Raised
$34.5M
Company Overview
Waypoint Bio is a biotechnology company that is developing a new generation of cell therapies designed to treat solid tumors. The company's platform utilizes spatial pooled screening technology, combining advances in AI/ML, computer vision, and pooled screening to perform high-throughput testing of cell therapy designs directly within in vivo models. This approach allows for the simultaneous measurement of hundreds of phenotypes at the single-cell level, aiming to accelerate the discovery and optimization of effective cell therapies for complex diseases like cancer. The company was co-founded by MIT alumni Xinchen Wang and David Phizicky.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine, Computer Vision
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Waypoint Bio Comps
Public and private peers based on sector, stage, and business model.
Waypoint Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 27, 2026 | ||||
| Seed | Jun 28, 2024 |
Key People
Founding team and executive leadership
Waypoint Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Time BioVentures | Series A |
| Mitsui Global Investment | Series A |
| Lux Capital | Series A |
| General Catalyst | Series A |
| Amplify Partners | Series A |
| Fifty Years | Seed |
| Recode Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
$20M round led by Amplify Partners.
- Oct 21, 2025
Patrick Kaifosh, formerly of Meta, appointed CTO.
Waypoint Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Waypoint Bio's valuation, stock price, and market status.
